Company Filing History:
Years Active: 2013
Title: Hanna-Karin Toftevall: Innovator in Nanoparticle Technology
Introduction
Hanna-Karin Toftevall is a prominent inventor based in Eslöv, Sweden. She has made significant contributions to the field of nanoparticle technology, particularly in the delivery of biomolecules. Her innovative work has the potential to advance medical and biological research.
Latest Patents
Toftevall holds a patent for a nanoparticle suitable for the delivery of a biomolecule into or out of a membrane-enclosed cell or cell organelle. This nano-sized particle is designed for in vitro or ex vivo biomolecule delivery to cell cultures through heat-induced endosomal release. The invention features a superparamagnetic core coated in a heat-sensitive coating, which includes membrane-disruptive components and binding sites for the attachment of biomolecules and markers. A method is also provided for introducing the release effect of a plurality of biomolecules and endosomal disrupture molecules by applying an alternating field to a cell culture harboring the described particle.
Career Highlights
Hanna-Karin Toftevall is currently associated with Genovis AB, where she continues to develop her innovative ideas. Her work has garnered attention for its potential applications in various fields, including drug delivery and cellular biology.
Collaborations
Toftevall collaborates with talented individuals such as Sarah Fredriksson and Sylvia Koivunen, contributing to a dynamic research environment.
Conclusion
Hanna-Karin Toftevall is a trailblazer in nanoparticle technology, with her patent offering promising advancements in biomolecule delivery systems. Her contributions are poised to make a significant impact in the scientific community.